Search

everythinglearnresearchcommunity

for

Search:↓

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Indian men have 62.1% hair loss, mostly grade II vertex, and less extensive than other populations.

Histopathology is not reliable for detecting early fibrosis in traction alopecia or for showing how severe it is.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Women using hair relaxers with alopecia had lower zinc levels, suggesting zinc deficiency might contribute to hair loss.

Certain factors like patchy hair loss at the back of the head, being female, and younger age at diagnosis can lead to a worse outcome for alopecia areata.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

The conclusion is that the best approach for treating Female Pattern Hair Loss is a combination of different treatments.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.

Lichen planus pigmentosus and fibrosing frontal alopecia in Colombia are likely different stages of the same disease.

About 40% of women by age 60 experience significant hair loss, often due to androgenetic alopecia, with treatments like minoxidil available and hope for future cures.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Androgenetic alopecia is common in South-West Nigeria, affecting more men than women, with stress worsening the condition.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

The supplement with amino acids, iron, selenium, and marine hydrolyzed collagen improved hair growth more than drug treatment alone, with most people tolerating it well.

Trichoscopy is effective for diagnosing and monitoring female pattern hair loss.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Oral isotretinoin temporarily improved skin symptoms in a child with IFAP syndrome.

Superficial cryotherapy is effective and safe for treating alopecia areata, especially eyebrow hair loss.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.